dr peter attia semaglutide Could GLP-1s impact aging and cognitive health? Ricardo - Thinking of adding
Description
New therapies could target energy expenditure directly FGF21-like drugs may complement GLP-1s, combining appetite control and metabolic activation for better, more sustainable outcomes
Your doctor will discuss these risks in detail, ensuring you're fully informed before starting treatment
What is Semaglutide
In studies, patients lost up to 1522% of their body weight with these GLP-1/GIP medications
Through their investigations, a team associated with the University of Southern California has recently identified and isolated MOTS-c, a peptide with remarkable properties that influence energy metabolism, insulin sensitivity, and cellular stress response [1]
